AIRS vs RARE · rev $82.3M vs rev $350.0M
Airsculpt Technologies Inc (AIRS) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Airsculpt Technologies Inc (AIRS) is a medical care facilities company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported AIRS revenue for 2026-06-30 was $82.3M. Net income was -$3.5M. AIRS currently screens at market cap $337.0M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
AIRS currently screens at market cap $337.0M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the AIRS and RARE stock pages for the full models.
Not investment advice.